A Dual-Functioning 5ʹ-PPP-NS1shRNA that Activates a RIG-I Antiviral Pathway and Suppresses Influenza NS1-Reference-Cited by-同舟云学术

A Dual-Functioning 5ʹ-PPP-NS1shRNA that Activates a RIG-I Antiviral Pathway and Suppresses Influenza NS1

Published:2020-03 Issue: Volume:19 Page:1413-1422
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Singh Neetu,Ranjan Priya,Cao Weiping,Patel Jenish,Gangappa Shivaprakash,Davidson Bruce A.,Sullivan John M.,Prasad Paras N.,Knight Paul R.,Sambhara Suryaprakash

Funder

Centers for Disease Control and Prevention

National Institutes of Health

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference43 articles.

1. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza;Hayden;N. Engl. J. Med.,1999

2. Baloxavir: First Global Approval;Heo;Drugs,2018

3. Oseltamivir resistance in human seasonal influenza viruses (A/H1N1) in EU and EFTA countries: an update;Influenza Project Team;Euro Surveill.,2008

4. Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe;Lackenby;Euro Surveill.,2008

5. Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08;Hauge;Emerg. Infect. Dis.,2009

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiviral Approaches against Influenza Virus;Clinical Microbiology Reviews;2023-03-23

2. RIG-I-Mediated Innate Immune Stimulation by Chemically Synthesized Long Double-Stranded RNAs Is Structure and Sequence Dependent;Nucleic Acid Therapeutics;2022-08-01

3. Enhancing anti-tumor efficacy and immune memory by combining 3p-GPC-3 siRNA treatment with PD-1 blockade in hepatocellular carcinoma;OncoImmunology;2022-01-02